Lunai Bioworks: Of The Original Report To Reflect The Company’s Receipt On April 28, 2026 Of An Additional Staff Determination Letter From The Listing Qualifications Staff Of The Nasdaq Stock Market Llc Regarding Compliance With Nasdaq Listing Rule 5550(b)(2). The Soliciting Material And Related Disclosures Included In The Original Report Under The Captions “the Special Meeting And The Proposals Being Voted On,” “additional Information And Where To Find It” And “participants In The Solicitation,” Are No Longer Applicable Because The Special Meeting Has Been Held And The Proposals Submitted To A Vote Of Stockholders Thereat Have Been Acted Upon

Show full article

This functionality is available for registred users only

• Full name
  Lunai Bioworks Inc.
• Registration country
  USA
• Industry
  Pharmaceutical Preparation and Biotechnology
• М/S&P/F
  *** / *** / ***